Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00308724 · ClinicalTrials.gov registry record · NA

Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care

A NA study, sponsored by Baylor College of Medicine.

Completed
Registry status
NA
Development phase
148
Enrollment target

NCT00308724 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 148 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00308724, a NA study, has completed, sponsored by Baylor College of Medicine.

COMPLETED
Registry status
NA
Development phase
148 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether cognitive behavior therapy (CBT) is effective in the treatment of generalized anxiety disorder (GAD) in adults age 60 and older in a primary care setting.

Interventions

  • BEHAVIORAL Cognitive Behavior Therapy
  • BEHAVIORAL Telephone check-in

Trial Details

FieldValue
Enrollment Target 148 participants
Start Date 2004-03
Est. Completion 2015-04
Phase NA

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT00308724

The ClinicalTrials.gov registry entry for NCT00308724 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavior Therapy is the first listed.

NCT00308724 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00308724 about?

NCT00308724 is a clinical study titled "Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care". The purpose of this study is to determine whether cognitive behavior therapy (CBT) is effective in the treatment of generalized anxiety disorder (GAD) in adults age 60 and older in a primary care setting.

What is the current status of trial NCT00308724?

This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2004-03. Estimated completion is 2015-04.

What interventions are being tested in trial NCT00308724?

The interventions under investigation include: Cognitive Behavior Therapy (BEHAVIORAL), Telephone check-in (BEHAVIORAL).

Who is sponsoring clinical trial NCT00308724?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.